These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36472932)

  • 1. Impact of Implementing Screening and Interventions to Target Prevention of Opioid Misuse and Accidental Overdose in the Inpatient Setting.
    Bjornson S; Grindeland CJ; Werremeyer AB
    J Pharm Pract; 2024 Apr; 37(2):442-447. PubMed ID: 36472932
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort study.
    Henry SG; Fang SY; Crawford AJ; Wintemute GJ; Tseregounis IE; Gasper JJ; Shev A; Cartus AR; Marshall BDL; Tancredi DJ; Cerdá M; Stewart SL
    J Gen Intern Med; 2024 Feb; 39(3):393-402. PubMed ID: 37794260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.
    Skoy E; Eukel H; Werremeyer A; Strand M; Frenzel O; Steig J
    J Am Pharm Assoc (2003); 2020; 60(1):117-121. PubMed ID: 31677933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Longitudinal Quality Initiative toward Improved Enhanced Recovery after Cesarean Pathways.
    Cojocaru L; Alton S; Pahlavan A; Coghlan M; Seung H; Trilling A; Kodali BS; Crimmins S; Goetzinger KR
    Am J Perinatol; 2024 Feb; 41(3):229-240. PubMed ID: 37748507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a pilot overdose education and naloxone distribution program for hospitalized general medical patients.
    Jakubowski A; Pappas A; Isaacsohn L; Castillo F; Masyukova M; Silvera R; Holaday L; Rausch E; Farooq S; Veltri KT; Cunningham CO; Bachhuber MA
    Subst Abus; 2019; 40(1):61-65. PubMed ID: 30475162
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.
    Skoy E; Werremeyer A; Steig J; Eukel H; Frenzel O; Strand M
    Subst Abus; 2021; 42(4):672-677. PubMed ID: 33044896
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study.
    Mercer F; Parkes T; Foster R; Steven D; McAuley A; Baldacchino A; Steele W; Schofield J; Matheson C
    Drug Alcohol Rev; 2023 Mar; 42(3):517-526. PubMed ID: 36165733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing an overdose education and naloxone distribution program in a health system.
    Devries J; Rafie S; Polston G
    J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing an Opioid Risk Reduction Program in the Acute Comprehensive Inpatient Rehabilitation Setting.
    Van SP; Yao AL; Tang T; Kott M; Noles A; Dabai N; Coslick A; Rojhani S; Sprankle LA; Hoyer EH
    Arch Phys Med Rehabil; 2019 Aug; 100(8):1391-1399. PubMed ID: 31121153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis.
    Hartmann RJ; Elder JD; Terrett LA
    CMAJ Open; 2021; 9(1):E79-E86. PubMed ID: 33514601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Opioid Use in the Intensive Care Unit and Its Impact Across Care Transitions: A Prospective Study.
    Hauser CD; Bell CM; Zamora RA; Mazur J; Neyens RR
    J Pharm Pract; 2024 Apr; 37(2):343-350. PubMed ID: 36259532
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.
    Chang CY; Jones BL; Hincapie-Castillo JM; Park H; Heldermon CD; Diaby V; Wilson DL; Lo-Ciganic WH
    Breast Cancer Res Treat; 2024 Apr; 204(3):561-577. PubMed ID: 38191684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone-Prescribing Practices in a Freestanding Rehabilitation Hospital.
    Stone SN; Curley N; Sheth M; Butler C; Margolis S
    Am J Phys Med Rehabil; 2024 Feb; 103(2):105-109. PubMed ID: 37339054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdose education and naloxone distribution for veterans with opioid use disorder: Results from a pilot initiative.
    Chang G; Davids M; Kershaw A
    J Addict Dis; 2017; 36(4):217-221. PubMed ID: 28548574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of the impact of Michigan's opioid prescribing legislation on discharge opioid prescribing at a single institution.
    Sadowski R; Hillaker E; Chavarria M; Khaliq F; Schwark A
    J Opioid Manag; 2022; 18(5):467-474. PubMed ID: 36226786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
    Nguyen AP; Glanz JM; Narwaney KJ; Binswanger IA
    JAMA Netw Open; 2020 Mar; 3(3):e201018. PubMed ID: 32219404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.
    Lin LA; Brummett CM; Waljee JF; Englesbe MJ; Gunaseelan V; Bohnert ASB
    J Gen Intern Med; 2020 Feb; 35(2):420-427. PubMed ID: 31820218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose.
    Skoy E; Frenzel O; Eukel H; Lothspeich E; Steig J; Strand M; Werremeyer A
    Prev Chronic Dis; 2022 Jul; 19():E41. PubMed ID: 35834737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Program evaluation of the Opioid and Naloxone Education (ONE Rx) program using the RE-AIM model.
    Strand MA; Eukel H; Frenzel O; Skoy E; Steig J; Werremeyer A
    Res Social Adm Pharm; 2020 Sep; 16(9):1248-1254. PubMed ID: 31812501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of Opioid Misuse Amongst Patients Receiving Pain Management for Sickle Cell Disease in An Urban Setting.
    Ahmed N; Okany N; Singh D; Rungkitwattanakul D; Weaver SB
    J Pharm Pract; 2024 Feb; 37(1):104-109. PubMed ID: 36120980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.